Xin yixue (Sep 2023)

Effect of MPV and β<sub>2</sub>-microglobulin on cardiac valve calcification in patients on maintenance hemodialysis

  • Yao Zhuan’ e, Wang Pengbo, Fu Qinjuan, Wang Wei, Song Qiong, Li Huan, Liu Ai, Zhang Peng

DOI
https://doi.org/10.3969/j.issn.0253-9802.2023.09.005
Journal volume & issue
Vol. 54, no. 9
pp. 634 – 638

Abstract

Read online

Objective To investigate the relationship between mean platelet volume (MPV) and β2-microglobulin and cardiac valve calcification (CVC) in maintenance hemodialysis patients, aiming to provide a basis for clinical prediction and diagnosis of CVC. Methods Seventy patients on regular hemodialysis were selected and divided into the non-CVC (n=36) and CVC groups (n=34) according to the presence or absence of CVC. Gender, age, dialysis age, blood phosphorus, blood calcium, parathyroid hormone, 25 hydroxy-vitamin D3, albumin, prealbumin, iron, unsaturated iron, transferrin, ferritin total iron binding capacity, alkaline phosphatase, lipids, β2-microglobulin, MPV and neutrophil-to-lymphocyte ratio (NLR) were statistically compared between two groups. The risk factors for the incidence of CVC were assessed by Logistic regression analysis. Results Compared with the non-CVC group, age, dialysis age, MPV, β2-microglobulin and NLR were significantly higher in the CVC group, and all differences were statistically significant (all P < 0.05). Logistic regression analysis showed that age (OR = 1.101,P = 0.018), MPV (OR = 2.894,P =0.003), and β2-microglobulin (OR = 1.064,P = 0.038) were the independent risk factors for the incidence of CVC in maintenance hemodialysis patients. Conclusion MPV and β2-microglobulin are closely associated with the occurrence and development of CVC in maintenance hemodialysis patients, which are independent risk factors affecting CVC.

Keywords